Ryan A. Bragg

1.7k total citations · 1 hit paper
37 papers, 1.3k citations indexed

About

Ryan A. Bragg is a scholar working on Organic Chemistry, Pharmaceutical Science and Spectroscopy. According to data from OpenAlex, Ryan A. Bragg has authored 37 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Organic Chemistry, 10 papers in Pharmaceutical Science and 8 papers in Spectroscopy. Recurrent topics in Ryan A. Bragg's work include Chemical Reactions and Isotopes (10 papers), Asymmetric Synthesis and Catalysis (8 papers) and Molecular spectroscopy and chirality (7 papers). Ryan A. Bragg is often cited by papers focused on Chemical Reactions and Isotopes (10 papers), Asymmetric Synthesis and Catalysis (8 papers) and Molecular spectroscopy and chirality (7 papers). Ryan A. Bragg collaborates with scholars based in United Kingdom, Sweden and Netherlands. Ryan A. Bragg's co-authors include Charles S. Elmore, Jonathan Clayden, Jennifer H. Pink, Anjum Ahmed, Philip A. Woods, Andrew D. Smith, Neil Westlund, Samreen A. Yasin, Lai Wah Lai and Catherine McCarthy and has published in prestigious journals such as Angewandte Chemie International Edition, ACS Nano and Chemical Communications.

In The Last Decade

Ryan A. Bragg

32 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Apolipoprotein E Binding Drives Structural and Compositional Rearrangement of mRNA-Containing Lipid Nanoparticles

2021 264 citations Federica Sebastiani, Marianna Yanez Arteta et al. ACS Nano profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ryan A. Bragg United Kingdom	17	705	461	292	223	221	37	1.3k
David‐Alexandre Buisson France	19	525 0.7×	329 0.7×	239 0.8×	209 0.9×	131 0.6×	42	1.1k
U. Obst-Sander Switzerland	12	1.2k 1.7×	577 1.3×	965 3.3×	130 0.6×	268 1.2×	13	1.9k
Sanjay Sarkhel India	15	413 0.6×	465 1.0×	89 0.3×	185 0.8×	309 1.4×	29	1.4k
Ralph Paulini Switzerland	15	479 0.7×	482 1.0×	92 0.3×	137 0.6×	107 0.5×	16	1.1k
András Kotschy Hungary	24	1.2k 1.7×	413 0.9×	112 0.4×	55 0.2×	144 0.7×	88	1.6k
Arjun Narayanan United States	13	765 1.1×	497 1.1×	323 1.1×	53 0.2×	70 0.3×	22	1.1k
Kap‐Sun Yeung United States	22	2.1k 3.0×	387 0.8×	163 0.6×	107 0.5×	481 2.2×	46	2.6k
Kateri A. Ahrendt United States	12	1.5k 2.2×	392 0.9×	57 0.2×	104 0.5×	404 1.8×	15	1.8k
Галина Л. Левит Russia	19	689 1.0×	560 1.2×	46 0.2×	167 0.7×	175 0.8×	114	1.2k
Sheila H. DeWitt United States	13	438 0.6×	573 1.2×	170 0.6×	150 0.7×	93 0.4×	23	1.0k

Countries citing papers authored by Ryan A. Bragg

Since Specialization

Citations

This map shows the geographic impact of Ryan A. Bragg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan A. Bragg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan A. Bragg more than expected).

Fields of papers citing papers by Ryan A. Bragg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan A. Bragg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan A. Bragg. The network helps show where Ryan A. Bragg may publish in the future.

Co-authorship network of co-authors of Ryan A. Bragg

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan A. Bragg. A scholar is included among the top collaborators of Ryan A. Bragg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan A. Bragg. Ryan A. Bragg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Engman, Helena, Nigel A. S. Taylor, Rhiannon Maudsley, et al.. (2026). Open‐Label Study Assessing Relative and Absolute Bioavailability of Oral Camizestrant Formulations and Food Effects in Healthy Postmenopausal Women. Clinical and Translational Science. 19(2). e70475–e70475.

Bragg, Ryan A., et al.. (2025). Advancing Isotope Labeling Technologies at AstraZeneca through Academic–Industrial Collaboration. ACS Medicinal Chemistry Letters. 16(7). 1221–1225. 1 indexed citations

Sørensen, Henrik Toft, et al.. (2024). Synthesis of Stable Isotope, Tritiated, and Carbon‐14 Labeled Balcinrenone. Journal of Labelled Compounds and Radiopharmaceuticals. 67(4). 145–153.

Lindsay, David M., et al.. (2024). Selective Deuteration and Tritiation of Pharmaceutically Relevant Sulfoximines. Angewandte Chemie International Edition. 64(5). e202417179–e202417179. 4 indexed citations

Miller, Claire, Martin Wild, Zhoupeng Zhang, et al.. (2024). A Phase I Study To Determine the Absolute Bioavailability and Absorption, Distribution, Metabolism, and Excretion of Capivasertib in Healthy Male Participants. Drug Metabolism and Disposition. 52(9). 939–948. 4 indexed citations

Li, Xueqing, Kristin Samuelsson, Lars Weidolf, et al.. (2024). Disposition of orally administered atuliflapon, a novel 5‐lipoxygenase‐activating protein inhibitor in healthy participants. Pharmacology Research & Perspectives. 12(5). e70029–e70029.

Li, Xueqing, Maria Heijer, Ryan A. Bragg, et al.. (2023). Mass Balance and Absorption, Distribution, Metabolism, and Excretion Properties of Balcinrenone following Oral Administration in Combination with Intravenous Microtracer in Healthy Subjects. Drug Metabolism and Disposition. 51(8). 995–1004. 7 indexed citations

Bragg, Ryan A., Maria Heijer, Linda C. Andersson, et al.. (2023). Application of Accelerator Mass Spectrometry to Characterize the Mass Balance Recovery and Disposition of AZD4831, a Novel Myeloperoxidase Inhibitor, following Administration of an Oral Radiolabeled Microtracer Dose in Humans. Drug Metabolism and Disposition. 51(4). 451–463. 6 indexed citations

Sebastiani, Federica, Marianna Yanez Arteta, Michael Lerche, et al.. (2021). Apolipoprotein E Binding Drives Structural and Compositional Rearrangement of mRNA-Containing Lipid Nanoparticles. ACS Nano. 15(4). 6709–6722. 264 indexed citations breakdown →

10.

Kerr, William J., et al.. (2020). Computationally-Guided Development of a Chelated NHC-P Iridium(I) Complex for the Directed Hydrogen Isotope Exchange of Aryl Sulfones. ACS Catalysis. 10(19). 11120–11126. 26 indexed citations

11.

Bragg, Ryan A., et al.. (2016). The synthesis of tritium, carbon‐14 and stable isotope labelled selective estrogen receptor degraders. Journal of Labelled Compounds and Radiopharmaceuticals. 59(11). 454–461. 4 indexed citations

12.

Elmore, Charles S. & Ryan A. Bragg. (2014). Isotope chemistry; a useful tool in the drug discovery arsenal. Bioorganic & Medicinal Chemistry Letters. 25(2). 167–171. 221 indexed citations

13.

Joannesse, Caroline, Craig P. Johnston, Louis C. Morrill, et al.. (2012). Isothiourea‐Mediated Asymmetric O‐ to C‐Carboxyl Transfer of Oxazolyl Carbonates: Structure–Selectivity Profiles and Mechanistic Studies. Chemistry - A European Journal. 18(8). 2398–2408. 31 indexed citations

14.

Woods, Philip A., Louis C. Morrill, Ryan A. Bragg, & Andrew D. Smith. (2011). Isothiourea‐Catalysed Asymmetric C‐Acylation of Silyl Ketene Acetals. Chemistry - A European Journal. 17(39). 11060–11067. 30 indexed citations

15.

Belmessieri, Dorine, Caroline Joannesse, Philip A. Woods, et al.. (2010). Structure-enantioselectivity effects in 3,4-dihydropyrimido[2,1-b]benzothiazole-based isothioureas as enantioselective acylation catalysts. Organic & Biomolecular Chemistry. 9(2). 559–570. 80 indexed citations

16.

Bragg, Ryan A., et al.. (2007). Synthesis of isotopically labelled AZD3409 and its metabolites. Journal of Labelled Compounds and Radiopharmaceuticals. 50(5-6). 426–427. 1 indexed citations

17.

Davies, Stephen J., Andrew Ayscough, R. Paul Beckett, et al.. (2003). Structure–activity relationships of the peptide deformylase inhibitor BB-3497: modification of the methylene spacer and the P1′ side chain. Bioorganic & Medicinal Chemistry Letters. 13(16). 2709–2713. 28 indexed citations

18.

Bragg, Ryan A., Jonathan Clayden, Gareth A. Morris, & Jennifer H. Pink. (2002). Stereodynamics of Bond Rotation in Tertiary Aromatic Amides. Chemistry - A European Journal. 8(6). 1279–1289. 79 indexed citations

19.

Bragg, Ryan A. & Jonathan Clayden. (2000). Using Symmetry to Monitor Geared Bond Rotation in Aromatic Amides by Dynamic NMR. Organic Letters. 2(21). 3351–3354. 29 indexed citations

20.

Bragg, Ryan A. & Jonathan Clayden. (1999). Diastereoselective ortholithiation and conformational control in stereospecific dearomatising anionic cyclisations. Tetrahedron Letters. 40(48). 8327–8331. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact